Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase

Chk1 kinase is a critical component of the DNA damage response checkpoint and Chk1 inhibitors are currently under clinical investigation. Chk1 suppresses oncogene-induced replication stress with Chk1 inhibitors demonstrating activity as a monotherapy in numerous cancer types. Understanding the mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wayne, Joanne, Brooks, Teresa, Massey, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356717/
https://www.ncbi.nlm.nih.gov/pubmed/27829224
http://dx.doi.org/10.18632/oncotarget.13119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356717/
https://www.ncbi.nlm.nih.gov/pubmed/27829224
http://dx.doi.org/10.18632/oncotarget.13119

Ejemplares similares